KRAS and cancer: Moreover, through an anchoring-independent three-dimensional growth inhibition assay, we found that SIAIS562055 significantly impeded the growth of KRAS-mutant cancer cells, while having a minimal effect on KRAS-WT cells (Fig. 2D).